SILO PHARMA, INC. Common Stock and Additional Paid-In Capital
SILO PHARMA, INC. (SILO) had Common Stock and Additional Paid-In Capital of $135.10 thousand as of 2022-08-29, per its 10-K filed 2023-03-24.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2023-03-24
- 2022-08-29: Common Stocks, Including Additional Paid in Capital $135.10K.
| Period end | Common Stocks, Including Additional Paid in Capital |
|---|---|
| 2022-08-29 | $135.10K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |